Tag: gene therapy market research

Uncover key drivers, emerging technologies, and competitive movements shaping the gene therapy market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Gene Therapy Market?

The gene therapy market has shown significant expansion in its size over the past few years. This market is projected to expand from $12.52 billion in 2024 to reach $16.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 30.7%. Factors contributing to its historical growth include increased spending on pharmaceutical R&D, a surge in public-private partnerships, government funding, and an increase in spinal muscular atrophy cases.

The gene therapy market is anticipated to experience significant expansion in the forthcoming years, with its size projected to reach $31.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.8%. This growth during the forecast period is primarily driven by an increasing prevalence of cancer cases, a rising aging demographic, enhanced spending on research and development in the pharmaceutical sector, and a growing focus on gene therapy. Noteworthy trends for this period involve improving business operations through securing regulatory clearances, strengthening business activities via strategic collaborations and partnerships, expanding business capabilities through tactical acquisitions, and reinforcing operational capacities through business scaling initiatives.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Growth Drivers Are Propelling The Gene Therapy Market?

The significant increase in incidences of cancer and other target diseases is necessitating effective treatments, thereby driving the growth of the gene therapy market. The global rise in cancer cases is expected to contribute to the expansion of the gene therapy market during the forecast period. For instance, in January 2022, the American Cancer Society estimated that there would likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, which translates to approximately 1,670 fatalities daily. Worldwide, lung, prostate, bowel, and female breast cancer are identified as the four most common types, collectively accounting for 43 percent of all new cancer cases. Therefore, the global increase in cancer incidence rates is anticipated to boost the demand for the gene therapy market in the coming years. Gene therapy is considered one of the most effective treatments in oncology. This treatment involves introducing new genes into cancerous cells or the surrounding tissue to either cause cell death or slow down cancer growth.

Which Segmentation Factors Are Most Significant In The Gene Therapy Market Analysis?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

What New Opportunities Are Emerging From Trends In The Gene Therapy Market?

Machine learning and artificial intelligence are experiencing growing adoption within the gene therapy market. Artificial intelligence (AI) involves the simulation of human intelligence in machines, which are programmed to exhibit their inherent intelligence. Machine learning forms a component of AI. Machine learning and AI enable companies in the gene therapy market to perform comprehensive analyses of all pertinent data, uncover insights into tumor and immune cell interactions, and facilitate a more accurate assessment of tissue samples, a process frequently debated among different evaluators. For example, in May 2023, Form Bio, a US-based life-sciences focused software company, unveiled FORMsightAI, an AI-based solution designed to predict and optimize manufacturing outcomes for cell and gene therapy constructs. This full-service offering combines advanced, adaptable AI models with Form Bio’s underlying platform and a proficient team of computational life sciences experts with backgrounds in biology, bioinformatics, and data science. FORMsightAI addresses typical problems encountered by cell and gene therapy developers, such as construct truncations and manufacturing contaminations, which are primary factors leading to unacceptably low manufacturing yields, extended time-to-market, and therapeutic safety issues.

Who Are The Most Influential Companies In The Gene Therapy Market?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Region Holds The Largest Share In The Gene Therapy Market Today?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Browse Through More Reports Similar to the Global Gene Therapy Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Gene Therapy Market By 2029?

The gene therapy market has witnessed substantial expansion in recent years. Its valuation is anticipated to climb from $12.52 billion in 2024 to $16.36 billion in 2025, progressing at a compound annual growth rate (CAGR) of 30.7%. This historical upward trend can be ascribed to increased pharmaceutical research and development expenditure, a rise in public-private collaborations, government funding, and a growing incidence of spinal muscular atrophy.

The gene therapy market is anticipated to experience significant expansion over the coming years. Its valuation is projected to reach $31.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.8%. This anticipated market expansion during the forecast period is fueled by several factors, including the rising incidence of cancer, an expanding elderly demographic, increased expenditure on research and development within the pharmaceutical industry, and an enhanced emphasis on gene therapy. Key trends expected during this period involve improving business functions via obtaining regulatory clearances, bolstering business endeavors through strategic alliances and partnerships, broadening business capacities through strategic purchases, and fortifying operational strengths through business expansions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Factors And Drivers Are Influencing The Gene Therapy Market In 2025?

The notable rise in the occurrence of cancer and other target diseases necessitates effective treatments, thereby fueling the expansion of the gene therapy market. This global increase in cancer diagnoses is projected to bolster the gene therapy market’s growth throughout the forecast period. As an illustration, the American Cancer Society reported in January 2022 that the US is expected to see approximately 1.9 million new cancer diagnoses and 609,360 cancer-related deaths, translating to roughly 1,670 daily fatalities. Globally, lung, prostate, bowel, and female breast cancer represent the four most prevalent forms, collectively responsible for 43 percent of all newly identified cancer cases. Consequently, the escalating global cancer incidence rate is expected to significantly increase the demand for the gene therapy market in the coming years. Within oncology, gene therapy stands out as a highly effective treatment option, which involves inserting new genes into cancerous cells or adjacent tissues to either induce cell death or impede cancer progression.

How Is The Gene Therapy Market Segmented?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Which Key Trends Are Expected To Influence The Gene Therapy Market In The Coming Years?

The adoption of machine learning and artificial intelligence is progressively increasing within the gene therapy market. Artificial intelligence (AI) involves machines simulating human intelligence, programmed to exhibit their inherent capabilities. Machine learning constitutes a subset of AI. Both machine learning and AI empower companies in the gene therapy sector to conduct comprehensive analyses of relevant data, identify interactions between tumor and immune cells, and provide more accurate evaluations of tissue samples, an aspect frequently debated among different evaluators. For example, in May 2023, Form Bio, a US-based software company focused on life sciences, introduced FORMsightAI, a new AI-driven solution set for predicting and optimizing the manufacturing outputs of cell and gene therapy constructs. This comprehensive solution integrates advanced, adaptable AI models with Form Bio’s foundational platform and a skilled team of computational life sciences experts with backgrounds in biology, bioinformatics, and data science. FORMsightAI addresses common challenges faced by cell and gene therapy developers, including construct truncations and manufacturing contaminations, which are primary contributors to unacceptably low manufacturing yields, extended timelines to market, and therapeutic safety issues.

Which Leading Companies Dominate The Gene Therapy Market Share?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

How Does The Gene Therapy Market Perform Across Key Geographic Regions?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Gene Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Browse Through More Reports Similar to the Global Gene Therapy Market 2025, By The Business Research Company

Wound Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Current Size And Growth Outlook For The Gene Therapy Market?

There has been a significant expansion in the gene therapy market size in the past few years. Projected growth indicates an increase from $12.52 billion in 2024 to $16.36 billion in 2025, reflecting a compound annual growth rate (CAGR) of 30.7%. The historical growth period witnessed an upsurge due to factors such as increased spending on pharmaceutical R&D, elevation in public-private partnerships, governmental funding, and escalating instances of spinal muscular atrophy.

We project substantial expansion within the gene therapy market in the years to come. Predictions estimate a growth to $31.48 billion by 2029, maintaining a compound annual growth rate (CAGR) of 17.8%. The progression during the prediction timeline is ascribed to the rising prevalence of cancer, an increasingly older population, more extensive spending on research and development in the drug sector, and heightened emphasis on gene therapy as market propellers. Key trends during this forecasted period encompass enhancing business procedures by garnering regulatory approvals, fortifying business operations through strategic collaborations and partnerships, broadening business competencies via strategic acquisitions, and bolstering operational capacities through business growth.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Gene Therapy Market?

The escalating prevalence of cancer and other targeted diseases is necessitating optimal therapies, thereby pushing the expansion of the gene therapy market. The global increase in cancer occurrences is expected to bolster the gene therapy market’s growth throughout the future projection period. For example, the American Cancer Society estimated in January 2022 that the U.S would witness about 1.9 million fresh cancer diagnoses and roughly 609,360 cancer-caused deaths, amounting to nearly 1,670 life losses every day. The four predominant cancer varieties around the world include lung, prostate, bowel, and female breast cancer, making up 43 percent of all newly diagnosed cancer cases. Consequently, the escalating rate of cancer globally is expected to spur the need for the gene therapy market in the upcoming years. Gene therapy, one of the highly effective oncological treatment methods, introduces new genes into a cancer cell or neighboring tissue to induce cell death or slow cancer’s proliferation.

Which Segments Define The Structure Of The Gene Therapy Market?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

What Strategic Shifts And Innovations Are Influencing The Gene Therapy Market?

Machine learning and artificial intelligence (AI) technologies are gradually becoming more prevalent in the gene therapy market. AI is essentially a machine version of human intellect, designed to reflect natural cognition. As a subset of AI, machine learning plays a key role. These technologies assist gene therapy market companies in thoroughly analysing pertinent data, shedding light on the interactions between tumors and immune cells, and providing improved accuracy in tissue sample evaluation, which often encounters disagreements between evaluators. For instance, in May 2023, Form Bio, an American bio software firm, introduced FORMsightAI. This innovative AI-based suite predicts and improves the production outcomes of cell and gene therapy constructs. It’s a comprehensive solution that merges state-of-the-art, adaptable AI models with Form Bio’s foundational platform, and a team of computational life sciences experts with experience in biology, bioinformatics, and data science. FORMsightAI is designed to resolve common problems cell and gene therapy developers encounter, such as construct truncations and manufacturing contaminations. These issues notably cause unacceptably low production yields, protracted market entry timescales, and safety concerns with therapies.

Who Are The Most Influential Companies In The Gene Therapy Market?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Region Is Forecasted To Lead The Gene Therapy Market In The Coming Years?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Gene Therapy Market From 2025 to 2029?

There has been a significant expansion in the gene therapy market over the recent years. The market, which stood at $12.52 billion in 2024, will escalate to $16.36 billion by 2025, marking a compound annual growth rate (CAGR) of 30.7%. The remarkable growth during the historical period can be attributed to factors such as increasing pharmaceutical R&D spendings, a surge in public-private collaborations, government funding and a rise in instances of spinal muscular atrophy.

In the coming years, the gene therapy market is predicted to experience significant expansion. It is projected to reach a value of “$31.48 billion in 2029, growing at a compound annual growth rate (CAGR) of 17.8%.” Factors influencing this trend include escalating cancer incidences, an expanding elderly population, increase in pharmaceutical research and development expenditure, and a heightened focus on gene therapy. Major forthcoming trends include procuring necessary regulatory approvals to improve business operations, strategic collaborations and partnerships to bolster commercial activities, strategic acquisitions to broaden operational capabilities, and business expansion for enhancing operational proficiency.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What Elements Are Contributing To Growth In The Gene Therapy Market?

There has been a substantial uptick in cases of cancer and other such critical diseases, necessitating the need for potent treatment methods and fuels the growth of the gene therapy market. The global escalation in cancer incidence is projected to influence gene therapy market expansion in the upcoming period. For example, the American Cancer Society provided data in January 2022, suggesting that there will probably be 1.9 million new cancer diagnoses and an estimated 609,360 cancer-related fatalities in the US, which is approximately 1,670 deaths on daily basis. The four cancers that are most commonly diagnosed worldwide – lung, prostate, bowel, and female breast cancer, make up for about 43 percent of all newly diagnosed cancer cases worldwide. Thus, the global surge in cancer occurrence is expected to stimulate demand in the gene therapy market in the near future. Gene therapy, which involves the introduction of new genes into cancerous cells or nearby tissue to provoke cell death or reduce cancer growth, is a highly effective treatment in oncology.

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Which Emerging Trends And Strategic Shifts Are Shaping The Gene Therapy Market?

The gene therapy market is increasingly integrating artificial intelligence (AI) and machine learning into its operations. AI imitates human cognitive abilities within computers, while machine learning is a subset of this field. These technologies aid organizations in the gene therapy sector in conducting comprehensive data analysis, drawing connections between tumor and immune cell interactions, and providing more precise assessments of tissue samples that are usually contested among various analysts. For instance, Form Bio, an American software firm specializing in life-sciences, released FORMsightAI in May 2023. This new AI-driven solution predicts and optimizes the production results of cell and gene therapy constructs. FORMsightAI is a comprehensive solution that blends advanced, flexible AI models with Form Bio’s foundational platform and the expertise of a talented team of computational life scientists with experience in biology, bioinformatics, and data science. It tackles prevalent problems encountered by cell and gene therapy developers regarding construct truncations and manufacturing contaminate, which are significant contributors to low production yields, increased market entry timelines, and therapeutic safety issues.

Who Are The Key Contributors To Growth In The Gene Therapy Market?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Region Is Projected To Lead The Gene Therapy Market By 2025?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Gene Therapy Market Expected to Grow Between 2025 And 2029?

The market size for gene therapy has experienced significant expansion in the recent past. The magnitude is projected to escalate from a whopping $12.52 billion in 2024, reaching up to $16.36 billion by 2025, marking a compound annual growth rate (CAGR) of 30.7%. Factors contributing to growth during the historic period include an increase in pharmaceutical research and development spending, surge in collaborations between the private sector and government, state-level investments, and an upsurge in instances of spinal muscular atrophy.

The gene therapy market is projected to experience significant expansion in the coming years, anticipated to reach $31.48 billion by 2029 with a remarkable compound annual growth rate (CAGR) of 17.8%. The expansion anticipated in the projection period finds its roots in the escalation of cancer incidences, the expanding elderly demographic, heightened pharmaceutical sector investment in R&D, and an amplified emphasis on gene therapy. Upcoming market trends in the projection time frame encompass improving business functions via regulatory approvals, augmenting commercial activities via strategic alliances and associations, stretching business scope with strategic investments, and fortifying operational capacities via business enlargement.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gene Therapy Market?

The significant increase in occurrences of cancer and other targeted diseases necessitates effective treatments, thus fueling the expansion of the gene therapy market. The escalating cancer instances worldwide are predicted to further the growth of the gene therapy market in the upcoming period. For example, the American Cancer Society reported in January 2022 that there are likely to be approximately 1.9 million fresh cancer cases and about 609,360 cancer-associated fatalities in the US alone, averaging about 1,670 deaths per day. The top four prevalent types of cancer globally; lung, prostate, bowel, and female breast cancer, make up 43 percent of all new cancer diagnoses. Therefore, the global surge in cancer occurrence rate is predicted to propel the demand for the gene therapy market in the ensuing years. Gene therapy serves as one of the most potent treatments in oncology, where new genes are infused into a cancerous cell or its accompanying tissue to either induce cell death or inhibit cancer proliferation.

Which Key Market Segments Comprise the Gene Therapy Market and Drive Its Revenue Growth?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Areas Are Leading Regions in the Gene Therapy Market Expansion Across the Globe?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theGene Therapy Market Over the Coming Years?

The adoption of machine learning and artificial intelligence within the gene therapy market is slowly but steadily increasing. Artificial Intelligence (AI) is essentially the replication of human cognition by machines, while machine learning operates as a subset of AI. Applications of machine learning and AI within gene therapy help companies perform in-depth data analyses, generate insights into tumor-immune cell interactions, and yield more precise evaluations of tissue specimens, an aspect often subject to differing interpretations. Case in point, Form Bio, a life-science software firm based in the US, unveiled FORMsightAI in May 2023. This novel AI solution predicts and optimizes the production outputs of both cell and gene therapy constructs. The FORMsightAI package merges innovative, flexible AI models with Form Bio’s foundational platform and a team of accomplished experts in computational life sciences with a depth of knowledge in biology, bioinformatics, and data science. FORMsightAI tackles frequent challenges such as construct truncations and manufacturing contaminations often experienced by cell and gene therapy developers. These issues majorly contribute to low production yields, delayed market entry, and therapeutic safety concerns.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

How Is the Gene Therapy Market Conceptually Defined?

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Fast Is The Gene Therapy Market Expected to Grow Between 2025 And 2029?#_x000D_

The market size for gene therapy has experienced significant expansion in the recent past. The magnitude is projected to escalate from a whopping $12.52 billion in 2024, reaching up to $16.36 billion by 2025, marking a compound annual growth rate (CAGR) of 30.7%. Factors contributing to growth during the historic period include an increase in pharmaceutical research and development spending, surge in collaborations between the private sector and government, state-level investments, and an upsurge in instances of spinal muscular atrophy._x000D_

_x000D_

The gene therapy market is projected to experience significant expansion in the coming years, anticipated to reach $31.48 billion by 2029 with a remarkable compound annual growth rate (CAGR) of 17.8%. The expansion anticipated in the projection period finds its roots in the escalation of cancer incidences, the expanding elderly demographic, heightened pharmaceutical sector investment in R&D, and an amplified emphasis on gene therapy. Upcoming market trends in the projection time frame encompass improving business functions via regulatory approvals, augmenting commercial activities via strategic alliances and associations, stretching business scope with strategic investments, and fortifying operational capacities via business enlargement._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp_x000D_

_x000D_

#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gene Therapy Market?#_x000D_

The significant increase in occurrences of cancer and other targeted diseases necessitates effective treatments, thus fueling the expansion of the gene therapy market. The escalating cancer instances worldwide are predicted to further the growth of the gene therapy market in the upcoming period. For example, the American Cancer Society reported in January 2022 that there are likely to be approximately 1.9 million fresh cancer cases and about 609,360 cancer-associated fatalities in the US alone, averaging about 1,670 deaths per day. The top four prevalent types of cancer globally; lung, prostate, bowel, and female breast cancer, make up 43 percent of all new cancer diagnoses. Therefore, the global surge in cancer occurrence rate is predicted to propel the demand for the gene therapy market in the ensuing years. Gene therapy serves as one of the most potent treatments in oncology, where new genes are infused into a cancerous cell or its accompanying tissue to either induce cell death or inhibit cancer proliferation._x000D_

_x000D_

#Which Key Market Segments Comprise the Gene Therapy Market and Drive Its Revenue Growth?#_x000D_

The gene therapy market covered in this report is segmented – _x000D_

_x000D_

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy_x000D_

2) By Vector: Viral Vector, Non-Viral Vector_x000D_

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders_x000D_

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations _x000D_

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Gene Therapy Market Expansion Across the Globe?#_x000D_

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Are the Key Market Trends in theGene Therapy Market Over the Coming Years?#_x000D_

The adoption of machine learning and artificial intelligence within the gene therapy market is slowly but steadily increasing. Artificial Intelligence (AI) is essentially the replication of human cognition by machines, while machine learning operates as a subset of AI. Applications of machine learning and AI within gene therapy help companies perform in-depth data analyses, generate insights into tumor-immune cell interactions, and yield more precise evaluations of tissue specimens, an aspect often subject to differing interpretations. Case in point, Form Bio, a life-science software firm based in the US, unveiled FORMsightAI in May 2023. This novel AI solution predicts and optimizes the production outputs of both cell and gene therapy constructs. The FORMsightAI package merges innovative, flexible AI models with Form Bio’s foundational platform and a team of accomplished experts in computational life sciences with a depth of knowledge in biology, bioinformatics, and data science. FORMsightAI tackles frequent challenges such as construct truncations and manufacturing contaminations often experienced by cell and gene therapy developers. These issues majorly contribute to low production yields, delayed market entry, and therapeutic safety concerns._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report_x000D_

_x000D_

#How Is the Gene Therapy Market Conceptually Defined?#_x000D_

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Forecast for the Gene Therapy Market from 2024 to 2025?#_x000D_

Over recent years, the gene therapy market has experienced tremendous expansion. It is expected to elevate from a value of $12.52 billion in 2024 to $16.36 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 30.7%. The swell in growth during the historical period can be ascribed to factors such as heightened pharmaceutical R&D spending, an increase in public-private collaborations, governmental funding, and a surge in instances of spinal muscular atrophy._x000D_

_x000D_

#What Is the Projected Market Size of the Gene Therapy Market?#_x000D_

Rapid expansion is anticipated for the gene therapy market in the coming years, with projections showing a leap to $31.48 billion by 2029, characterized by a compound annual growth rate (CAGR) of 17.8%. Factors contributing to this predicted growth during the forecast period include a surge in cancer cases, an aging demographic, increased pharmaceutical R&D investment and a stronger emphasis on gene therapy. Key trends expected to emerge during the forecast period include acquiring regulatory permissions to improve business functions, fortifying business activities via strategic alliances and partnerships, growing business capabilities via strategic takeovers, and bolstering operational competencies through business expansions._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp_x000D_

_x000D_

#Who are the Major Competitors in the Gene Therapy Market Outlook?#_x000D_

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi_x000D_

_x000D_

#What Is Fueling Growth in the Gene Therapy Market?#_x000D_

The escalating incidence of cancer and other specific diseases is necessitating compelling solutions, resulting in a surge in the gene therapy market’s growth. A global increase in cancer cases can be expected to stimulate the expansion of this market throughout the upcoming years. For instance, the American Cancer Society revealed in January 2022 that the US is likely to see about 1.9 million new cancer diagnoses and approximately 609,360 deaths related to cancer, translating to around 1,670 deaths daily. The four most prevalent types of cancer globally, lung, prostate, bowel, and female breast cancer, represent 43 percent of all new cancer instances. Consequently, the global surge in the rate of cancer incidences is predicted to spark an increased demand for the gene therapy market in the near future. Known as one of the most efficient treatments in oncology, gene therapy introduces new genes within a cancerous cell or its surrounding tissue, effectively inducing cell death or inhibiting the cancer growth._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp_x000D_

_x000D_

#Which Gene Therapy Market Segments Are Growing the Fastest?#_x000D_

The gene therapy market covered in this report is segmented –_x000D_

_x000D_

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy_x000D_

2) By Vector: Viral Vector, Non-Viral Vector_x000D_

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders_x000D_

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations_x000D_

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques_x000D_

_x000D_

#Which Industry Trends Are Shaping the Future of the Gene Therapy Market?#_x000D_

Machine learning and artificial intelligence are steadily becoming more prevalent in the gene therapy market. AI emulates human intelligence in machines, which are configured to demonstrate their inherent intelligence. Machine learning, a component of AI, enables companies in the gene therapy market to thoroughly review all pertinent data, obtain insights into tumor and immune cell interactions, and provide a more precise assessment of tissue samples, a common source of conflict among different evaluators. For example, Form Bio, a US-based software company specializing in life sciences, introduced FORMsightAI, a novel AI-powered solution set for forecasting and improving cell and gene therapy constructs manufacturing outputs, in May 2023. This comprehensive solution merges state-of-the-art, flexible AI models with Form Bio’s foundational platform and a competent team of computational life sciences professionals with expertise in biology, bioinformatics, and data science. FORMsightAI tackles common challenges encountered by cell and gene therapy developers like construct truncations and manufacturing contaminations, which are primary reasons for unacceptable low manufacturing yields, delayed market timelines, and therapeutic safety issues._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report_x000D_

_x000D_

#Which Countries Are Leading the Gene Therapy Market?#_x000D_

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the gene therapy market, and how is it changing globally?_x000D_

2. Who are the major companies in the gene therapy market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the gene therapy market right now?_x000D_

4. Which products or customer segments are growing the most in the gene therapy market?_x000D_

5. What factors are helping or slowing down the growth of the gene therapy market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the gene therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Gene Therapy Market Size from 2025 to 2034?

In the past few years, there has been a remarkable growth in the size of the gene therapy market. It is projected to escalate from $12.52 billion in 2024 to $16.36 billion in 2025, marking a compound annual growth rate (CAGR) of 30.7%. The noteworthy growth during the historic period is credited to factors such as increased pharmaceutical R&D spending, proliferation of public-private collaborations, government funding, and a surge in instances of spinal muscular atrophy.

Accelerated expansion is anticipated in the gene therapy market size over the next few years. With a compound annual growth rate (CAGR) of 17.8%, it is projected to reach $31.48 billion by 2029. The projected growth during this period is largely due to the escalating number of cancer cases, the aging population swell, rising expenditure in pharmaceutical research and development, and an intensifying focus on gene therapy. Key trends for the forecast period encompass procuring regulatory approvals to enhance business procedures, fortifying business activities via strategic collaborations and partnerships, broadening business prowess through tactical acquisitions, and bolstering operational capacities through business expansions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What are the Fundamental Drivers and Innovations Shaping the Gene Therapy Market?

The growing incidence of cancer and other targeted diseases is necessitating efficient treatments, thereby fueling the gene therapy market’s expansion. The surge in global cancer rates is expected to significantly boost the gene therapy market over the projection period. For example, the American Cancer Society predicts that in January 2022, there may be around 1.9 million new cancer cases and 609,360 cancer-related deaths in the US, with approximately 1,670 deaths occurring each day. Lung, prostate, bowel, and female breast cancer are globally the four most common cancer types, comprising 43 percent of all newly diagnosed cancer cases. Hence, the global increase in cancer cases is presumed to drive demand for the gene therapy market in the coming years. Gene therapy, one of the most efficient cancer treatments, involves introducing new genes into a cancer cell or its surrounding tissue to trigger cell death or slow cancer growth.

How Is the Gene Therapy Market Segmented?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Regions Are Driving the Next Phase of the Gene Therapy Market Growth?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Gene Therapy Market?

The gene therapy market is slowly but surely embracing machine learning and artificial intelligence. AI, which replicates human intelligence in machines, and machine learning, a component of AI, are proving to be beneficial in the deep analysis of significant data. These technologies are providing critical insights into tumor-immune cell interactions and offer a more precise assessment of tissue samples, a topic often subject to contention among various evaluators. For example, in May 2023, FORMsightAI, a fresh AI-driven solution for forecasting and enhancing cell and gene therapy constructs’ production outputs was introduced by US-based Form Bio. Leveraging advanced AI models, Form Bio’s foundational platform, and experts in computational life science, FORMsightAI is a comprehensive solution. It addresses key challenges in cell and gene therapy development like construct truncations and manufacturing contaminations, which often lead to low manufacturing yields, delayed market entry, and safety concerns in therapeutics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

How Is the Gene Therapy Market Defined and What Are Its Core Parameters?

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Gene Therapy Market?

The escalating rate of cancer and other targeted diseases is demanding effective remedies, thus fueling the expansion of the gene therapy market. The increasing global cancer incidence will likely foster the growth of the gene therapy market in the years to come. For instance, the American Cancer Society estimated in January 2022 that approximately 1.9 million fresh cancer diagnoses and 609,360 cancer-related deaths would occur in the US in a single year, roughly translating to 1,670 deaths each day. The most prevalent cancer types worldwide include lung, prostate, bowel, and female breast cancer, representing 43 percent of all new cancer diagnoses. Hence, the global surge in cancer rates is likely to stimulate the demand for the gene therapy market in the future. In oncology, gene therapy offers one of the most efficient treatment approaches. The process involves implanting new genes into a cancer cell or its surrounding tissue to induce cell death or inhibit cancer growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

#What Growth Opportunities Will Drive the Gene Therapy Market’s CAGR Through 2034?

In the past few years, the market size of gene therapy has seen a significant surge. The market, which is currently valued at $12.52 billion in 2024, is projected to escalate to $16.36 billion in 2025, with a compound annual growth rate (CAGR) of 30.7%. Factors such as an increase in pharmaceutical R&D spending, augmented public-private collaborations, governmental funding, and a spike in instances of spinal muscular atrophy have heavily contributed to this historical growth phase.

The gene therapy market is poised for rapid expansion in the upcoming years. The anticipated growth will have it reach a worth of $31.48 billion by 2029, with a compound annual growth rate (CAGR) of 17.8%. This predicted growth during the forecast period is largely a result of factors such as a spike in cancer incidents, an aging global population, increased expenditure in research and development in the pharmaceutical segment, and heightened attention on gene therapy. Key trends forecasted for this period include obtaining regulatory approvals to enhance business operations, fortifying business activity via strategic collaborations and partnerships, broadening business capacity through strategic acquisitions, and intensifying operational capabilities through business expansion.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

What Are the Most Significant Market Trends Transforming theGene Therapy Market?

Machine learning and artificial intelligence are slowly but surely making their mark in the gene therapy market. AI mimics human cognition in machines, which are programmed to demonstrate inherent intelligence, with machine learning forming a component of this. It assists companies in the gene therapy market in conducting in-depth data analysis, providing insights on tumor and immune cell interactions, and delivering a more precise appraisal of tissue samples, often a point of contention among various evaluators. Take, for instance, in May 2023, Form Bio, a US-based biotechnology software firm, unveiled its revolutionary AI-powered solution, FORMsightAI, designed to predict and enhance the production outputs of cell and gene therapy constructs. This comprehensive solution integrates revolutionary, flexible AI models with Form Bio’s integral platform and a proficient team of computational life science experts possessing backgrounds in biology, bioinformatics, and data science. FORMsightAI takes on frequent problems encountered by cell and gene therapy developers, such as construct truncations and manufacturing contaminations, which are primarily responsible for unacceptably low production yields, drawn-out market-ready timelines, and issues concerning therapeutic safety.

What Are the Top Market Players Propelling the Growth of theGene Therapy Industry?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Primary Segments of the Gene Therapy Market Are Driving Growth and Industry Transformations?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Gene Therapy Market?# Market?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Gene Therapy Market 2025, By The Business Research Company:

Colorectal Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Thyroid Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Hematology Analyzers and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the gene therapy market grown in recent years?

In recent times, the growth of the gene therapy market size has been exponential. The market is projected to expand from $12.52 billion in 2024 to $16.36 billion in 2025 with a compound annual growth rate (CAGR) of 30.7%. The historical growth can be traced back to increasing pharmaceutical research and development expenditures, growing public-private collaborations, government funding, and an uptick in spinal muscular atrophy instances.

How is the gene therapy market size expected to evolve during the forecast period?

Anticipated to witness a significant rise in the next couple of years, the market size of geospatial analytics is projected to reach $209.26 billion in 2029 with an impressive compound annual growth rate of 19.0%. The surge during the forecast period can be linked to various factors such as the establishment of smart cities, the implementation of precision farming, healthcare and epidemic tracking, amalgamation with IoT and huge data, as well as environmental preservation initiatives. Key trends during the forecast timeframe include geospatial big data analytics, mobile geospatial applications, blockchain interfaces for spatial data protection, social media combined with geospatial analysis, and urban mobility along with smart city planning.

Get your gene therapy market report here!

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which key drivers are propelling the gene therapy market’s growth?

Significant growth in the gene therapy market is being driven by the escalating incidents of cancer and various other diseases requiring effective treatment. The global increase in cancer cases is expected to contribute to the expansion of the gene therapy market in the projected timeframe. In particular, the American Cancer Society projected in January 2022 that there will be 1.9 million fresh diagnoses of cancer and around 609,360 cancer-related deaths in the United States alone, equating to approximately 1,670 fatalities daily. Lung, prostate, bowel, and female breast cancer are the four most common types, accounting for 43% of all new cases of cancer. Accordingly, the global rise in cancer rates is expected to stimulate demand for the gene therapy market in the coming years. One of the most effective treatment options in oncology is gene therapy, where new genes are introduced into a cancer cell or the surrounding tissue to inhibit cancer growth or result in cell death.

What are the market segments in the gene therapy industry?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which leading companies are shaping the growth of the gene therapy market?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

What key trends are currently impacting the gene therapy market’s development?

The gene therapy market is increasingly embracing machine learning and artificial intelligence (AI). AI mimics human intelligence within machines that have been programmed to express inherent intelligence. Machine learning, a subset of AI, in tandem with AI assists businesses in the gene therapy arena to conduct exhaustive analysis of pertinent data. They decipher the relationship between tumor and immune cell interactions and provide a more precise assessment of tissue samples, which is often a point of contention among various evaluators. For example, Form Bio, an American life-sciences software firm pioneered FORMsightAI, a novel AI-run solution set for forecasting and enhancing manufacturing yields of cell and gene therapy structures in May 2023. This comprehensive solution merges innovative, flexible AI models with Form Bio’s foundational platform and a seasoned team of computational life sciences experts equipped with know-how in biology, bioinformatics, and data science. FORMsightAI tackles recurrent challenges encountered by cell and gene therapy developers such as construct truncations and manufacturing contaminations. These are leading reasons for deeply unsatisfactory manufacturing yields, protracted market entry timelines, and issues concerning therapeutic safety.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

Which geographic areas are influencing the growth of the gene therapy market?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/car-t-therapy-market

Nucleic Acid Based Gene Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: